Gubra AS (OCSE:GUBRA) Days Payable : 38.26 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Days Payable?

Gubra AS's average Accounts Payable for the six months ended in Dec. 2023 was kr9.1 Mil. Gubra AS's Cost of Goods Sold for the six months ended in Dec. 2023 was kr43.3 Mil. Hence, Gubra AS's Days Payable for the six months ended in Dec. 2023 was 38.26.

The historical rank and industry rank for Gubra AS's Days Payable or its related term are showing as below:

OCSE:GUBRA' s Days Payable Range Over the Past 10 Years
Min: 18.82 Med: 24.38 Max: 44.57
Current: 38.86

During the past 5 years, Gubra AS's highest Days Payable was 44.57. The lowest was 18.82. And the median was 24.38.

OCSE:GUBRA's Days Payable is ranked worse than
78.73% of 724 companies
in the Biotechnology industry
Industry Median: 148.12 vs OCSE:GUBRA: 38.86

Gubra AS's Days Payable declined from Dec. 2022 (40.25) to Dec. 2023 (38.26). It may suggest that Gubra AS accelerated paying its suppliers.

Gubra AS Days Payable Historical Data

The historical data trend for Gubra AS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Days Payable Chart

Gubra AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

18.82

20.09

28.67

44.57

Gubra AS Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			-	18.31	40.25	33.90	38.26

Competitive Comparison of Gubra AS's Days Payable

For the Biotechnology subindustry, Gubra AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Days Payable distribution charts can be found below:

* The bar in red indicates where Gubra AS's Days Payable falls into.

Gubra AS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Gubra AS's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (10.592	+	11.405)	/	2 )	/	90.069	*	365
=	10.9985					/	90.069	*	365
=	44.57

Gubra AS's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.768	+	11.405)	/	2 )	/	43.346	*	365 / 2
=	9.0865					/	43.346	*	365 / 2
=	38.26

Gubra AS Days Payable Related Terms

Thank you for viewing the detailed overview of Gubra AS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS (OCSE:GUBRA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PI3:Germany

Address

Hørsholm Kongevej 11B, Hørsholm, DNK, 2970

Website

https://www.gubra.dk

Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines